GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for polyribonucleotide nucleotidyltransferase (Q2SMK9)

Analyse AlphaFold monomer V2.0 prediction for polyribonucleotide nucleotidyltransferase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q2SMK9
Type
protein
Length
703 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xbb2F1C7CB3A1eeFAc24fCa72cc627162D5413FD7
Molecule
Polyribonucleotide nucleotidyltransferase
UniProt
Q2SMK9
Pockets
3 · best druggability 0.76

Structure

1 distinct chain · 35% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APolyribonucleotide nucleotidyltransferaseprotein70335% helix, 30% strandQ2SMK9

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19250.760.7985empty
26320.650.7564empty
3520.260.7412empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.